Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 3Phase 1 3Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 23Colorectal Neoplasms 4Biliary Tract Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancoast Syndrome 1Neoplasms 1Locally Advanced Gastric or Gastroesophageal Junction Cancer 1Locally Advanced Gastric Adenocarcinoma 1Klatskin Tumor 1Hand-Foot Syndrome 1Gastric Adenocarcinoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1Adenocarcinoma 1

Interventions

Gemcitabine 13Cisplatin 11durvalumab 7Oxaliplatin 5Capecitabine 5Fluorouracil 4S 1 (combination) 3Leucovorin 3Irinotecan 3zanidatamab 2gemcitabine-oxaliplatin regimen 2Trastuzumab 2trastuzumab deruxtecan 1pembrolizumab 1niraparib 1neratinib 1ivosidenib 1futibatinib 1envafolimab 1encorafenib 1binimetinib 1becatecarin 1Tegafur 1Pancreaticojejunostomy 1NUC-1031 1Folfox protocol 1Drug Therapy 1Chemotherapy, Adjuvant 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Biliary Tract Neoplasms × S 1 (combination) × Clear all
NCT05771480 2026-04-21

TOURMALINE

AstraZeneca

Phase 3 Active not recruiting
142 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT06109779 2026-03-04

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

AstraZeneca

Phase 3 Active not recruiting
757 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT02182778 2019-02-21

GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 3 Completed
246 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡